As debate about the usefulness and ethics of generative artificial intelligence (AI) continues, the pharmaceutical industry needs to consider the advantages it can offer, especially for inc
Digital transformation has long been a priority for all life science companies and it has been made even more pressing by the current health emergency caused by COVID-19.